(PRWEB) November 13, 2017 -- QURE Healthcare, LLC today announced the appointment of Joe McKenna to QURE’s Board of Directors. Mr McKenna is currently Vice President of Customer Growth & Success at Proteus Digital Health where he is responsible for commercial development with health systems and payers across the country.
“Joe is an accomplished and talented sales executive with experience connecting health system leaders with new solutions to improve care quality and efficiency,” said Dr. John Peabody, President and Founder of QURE. “Joe has been a trusted advisor and sounding board for QURE, and we are very pleased to formally welcome him to the Board. I am confident that his experience and perspective will make significant contributions as QURE enters our next phase of rapid growth.”
Prior to his work at Proteus, Joe spent nearly 15 years at the Advisory Board Company, most recently as a Managing Principle for National and Strategic Accounts where he led the company’s rapid sales growth among large academic medical centers and progressive multi-state health systems. He is graduate of Bates College.
Mr. McKenna joins an Exceptional Board of Advisors at QURE led by Todd Johnson, CEO of HealthLoop and national leader in healthcare IT that focuses on putting patients first; Molly O’Neill, Chief Commercial Officer at Proteus and former vice Chancellor of Duke Medicine; Patrick Flanagan, CEO of Veristat and overseeing its remarkable, recent growth; and Ray Lynch, the newly appointed CFO at Fox Chase Cancer Center and former Executive Director of the NCI designated Huntsman Cancer Hospital.
About QURE Healthcare.
QURE Healthcare is a research and business firm committed to improving the quality of clinical care. QURE uses its proprietary software technology, CPV® (Clinical Performance and Value) vignettes, to evaluate clinical practice and cost-effectiveness of healthcare services at the level of physicians or health care providers. CPV® vignettes are used in health systems in the US and over 30 countries worldwide. Core services include CPV™ studies, health economic analyses, and physician-level data collection. The ease, validity and affordability of CPV™ vignettes attract a wide array of clients: payers, hospital systems, life sciences and medical technology companies, medical licensing and education institutions as well as international health development organizations. For more information visit LinkedIn, https://twitter.com/QURE_Healthcare and http://www.qurehealthcare.com.
Othman Ouenes, QURE Healthcare, http://www.qurehealthcare.com, +1 (415) 321-3388 Ext: 20, [email protected]
SOURCE QURE Healthcare